Solgar Prime will be introduced later this year in the United States and Europe, with further expansion to Asia in 2027. The line supports the company’s focus on healthy longevity as a strategic growth platform.
By 2040, nearly half of the world’s population will be over 40, making healthy longevity and proactive nutrition important drivers of future growth, stated Nestlé. These segments are expected to deliver double-digit growth through 2031.
“Healthy longevity is one of the most dynamic growth areas in consumer health,” said Serena Aboutboul, head of the nutrition & health strategic business unit at Nestlé, in a press release. “As people live longer and seek to live healthier lives, they are increasingly looking for ways to maintain their strength, vitality and mobility over time.
“Solgar Prime expands our portfolio of science-based nutritional solutions designed to address those evolving needs and reflects our continued focus on helping people live healthier lives for longer.”
The Solgar Prime range includes Vitality Creatine Complex, a daily powder formulated to help support muscle strength, energy, mobility, and bone and cartilage health. Studies show that creatine supplementation can help increase lean muscle mass and muscular strength, both of which typically decline with age.
The range also includes Hair Growth Complex, with biotin and zinc, to support thicker, fuller hair.
Interest in healthy-longevity
The Swiss multi-national has held a long interest in the healthy-longevity space, with the company having launched the Celltrient product line for cellular aging in 2020 in the U.S., which it has since rebranded as Solgar Cellular Nutrition. That line is no longer listed on the brand’s U.S. website.
Nestlé has taken a two-pronged approach to the category, by investing in players such as ChromaDex (now Niagen Bioscience) for nicotinamide riboside (NR) and Amazentis (which owns the Timeline consumer brand and markets the Mitopure ingredient for mitochondrial health), for Urolithin A.
The company’s scientists are also exploring the potential of nicotinamide and pyridoxine to stimulate muscle stem cells and the olive polyphenol oleuropein to reverse mitochondrial dysfunction and impaired muscle mass and muscle performance during sarcopenia.
Another compound of interest is trigonelline, a naturally occurring alkaloid and structurally related to nicotinic acid (vitamin B3), which is reported to be decreased in older people with sarcopenia. Levels of the compound also correlate positively with muscle strength.
Data from studies with Caenorhabditis elegans, mice and humans indicated that trigonelline supplementation could boost NAD+ levels, with additional insights from the C. elegans experiments showing that trigonelline may reduce age-related muscle wasting and increase lifespan (Nature Metabolism).
Philipp Gut, healthy longevity research lead for Nestlé R&D, will deliver a presentation at the upcoming Nutra Healthspan Summit in London, November 10-11 to discuss the company’s interest in mitochondrial function and aging. For more information and to register, please click HERE.
A focus on premium positioning
Solgar was included in Nestlé’s US$5.75 billion acquisition of The Bountiful Company in 2021 and was the sole premium brand in a portfolio that included Nature’s Bounty, Osteo Bi-Flex and Puritan’s Pride. Those latter brands were included in the recent divestiture of Nestlé’s Holistic Health portfolio to private equity firm Yellow Wood Partners for US$1 billion.
Philipp Navratil, CEO of Nestlé, described the sale as “another important step in the strategic transformation of our portfolio. We are focusing our resources where we have the strongest competitive advantage,” he said, and highlighted the performance of Solgar and Pure Encapsulations.
